Please use this identifier to cite or link to this item: http://hdl.handle.net/11054/21
Title: Sepsis management and anti-endotoxin therapy after nebacumab: a reappraisal.
Authors: Hurley, James C.
Issue Date: 1994
Publisher: ADIS Press
Place of publication: Auckland, New Zealand
Publication Title: Drugs
Volume: 47
Issue: 6
Start Page: 855
End Page: 861
URI: http://hdl.handle.net/11054/21
ISSN: 0012-6667
Internal ID Number: 00008
Health Subject: ANIMALS
ANTIBODIES - MONOCLONAL ADVERSE EFFECTS
ANTIBODIES - MONOCLONAL - THERAPEUTIC USE
CLINICAL TRIALS AS TOPIC
DEXAMETHASONE THERAPEUTIC USE
ENDOTOXINS
IMMUNOLOGY
GRAM NEGATIVE BACTERIAL INFECTIONS
DRUG THERAPY
HUMANS
METHYLPREDNISOLONE - THERAPEUTIC USE
NEBACUMAB
DEXAMETHASONE
METHYLPREDNISOLONE
Type: Journal Article
Article
Appears in Collections:Research Output

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.